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Background: Gene therapy is a promising approach to the treatment of a wide range of diseases. 
The development of efficient and adequate gene delivery systems could be one of the most impor-
tant factors. Polyethyleneimine, a cationic polymer, is one of the most successful and widely used 
vectors for nonviral transfection in vitro and in vivo.
Methods: A novel biodegradable poly(ester amine) copolymer (PEA) was successfully 
prepared from low molecular weight polyethylenimine (PEI, 2000 Da) and poly(L-lactide) 
copolymers.
Results: According to the results of agarose gel electrophoresis, particle size and zeta poten-
tial measurement, and transfection efficiency, the PEA copolymers showed a good ability to 
condense plasmid DNA effectively into nanocomplexes with a small particle size (#150 nm) 
and moderate zeta potential ($10 mV) at an appropriate polymeric carrier/DNA weight ratio. 
Compared with high molecular weight PEI (25kDa), the PEA obtained showed relatively high 
gene transfection efficiency as well as low cytotoxicity in vitro.
Conclusion: These results indicate that such PEA might have potential application as a gene 
delivery system.
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Introduction
In recent decades, gene therapy has attracted attention from researchers in the fields 
of medicine, pharmaceutical sciences, and biotechnology due to its potential to treat 
chronic diseases and genetic disorders.1,2 Although viral vectors generally yield 
higher gene expression, there are concerns over the immunogenicity, cytotoxicity, and 
recombinogenic potential of viral gene transfer. Due to the improved safety   profile and 
ease of preparation and manipulation, nonviral techniques for gene delivery   continue 
to be explored and optimized. Nonviral vectors have merit because of their low immu-
nogenicity, low cytotoxicity, low production cost, and reproducibility.3 However, 
the primary obstacle to implementing effective gene therapy using nonviral vectors 
remains their relatively inefficient gene delivery in vitro and in vivo.
One of the most successful and widely studied cationic polymers for gene delivery 
reported to date is polyethylenimine (PEI), which contains primary, secondary, and 
tertiary amines, so has the ability to combine with both DNA and siRNA, a characteristic 
known as the “proton sponge effect.” Branched 25 kDa PEI with high transfection International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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efficiency has been regarded as the gold standard for nonviral 
vectors. However, due to its cytotoxicity in many cell lines, its 
application is limited. Low molecular weight PEI is usually 
not cytotoxic, but has lower transfection efficiency. In order 
to enhance the efficiency of gene delivery and minimize 
the cytotoxicity of PEI, several   modified PEI, including 
degradable hyperbranched poly(ester amine) copolymers 
(PEA),4 crosslinked low molecular weight PEI,5 PEI-chitosan, 
and biodegradable PEI,6–8 have been investigated as gene 
carriers to reduce cytotoxicity and increase transfection 
efficiency. Arote et al recently synthesized a novel 
degradable PEA based on low molecular weight of PEI and 
polycaprolactone. They reported that the PEA obtained had 
low cytotoxicity and high transfection efficiency due to the 
hydrophobicity of polycaprolactone.7 However, due to its high 
degree of crystallinity and considerable hydrophobicity, the 
degradation rate of polycaprolactone is very slow, so it is not 
easy to absorb in the body.
Polylactide (PLA) and poly(D, L-lactide-co-glycolide) 
(PLGA) are the most commonly used biodegradable 
polymers. These have been approved by the US Food and 
Drug Administration for some human clinical applications, 
due to their good biocompatibility and biodegradability.9 
PLGA/PEI and PLA/PEI nanoparticles might be useful in 
delivery of pDNA. Future studies will focus on optimizing 
PLA/PEI and PLGA/PEI nanoparticles for in vivo use as 
gene delivery systems.10,11
In this paper, a novel degradable water-soluble branched 
PEA based on PLA and low molecular weight branched PEI 
was prepared and characterized. The DNA condensation 
ability, protective ability, particle sizes, and zeta potentials of 
PEA were investigated. We observed remarkable transfection 
efficiency and significantly lower cytotoxicity with these 
polymers as compared with PEI (25 kDa).
Materials and methods
reagents
Branched PEI (molecular weight 2000 Da), L-lactide, 1,4-
  butanediol, isophorone di-isocyanate (IPDI), deoxyribonu-
clease I (DNase I), Dulbecco’s Modified Eagle’s Medium, 
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) were obtained from Sigma-Aldrich, St 
Louis, MO. Dimethyl sulfoxide, dibutyl tin dilaurate, 
  stannous octoate (Sn(Oct)2), 1,1,1-trichloroethane,   methanol, 
  petroleum ether, and anhydrous dichloromethane were 
  purchased from Chengdu KeLong Chemicals, Sichuan, 
People’s Republic of China. All the chemicals used were of 
analytical grade and used as received.
cell lines and cell culture
Human embryonic kidney 293 (HEK293) cells and a human 
hepatocellular carcinoma (HepG-2) cell line were incubated 
in Dulbecco’s Modified Eagle’s Medium containing 10% fetal 
bovine serum and 1% antibiotics (penicillin-streptomycin, 
100 U/mL) at 37°C in a humidified atmosphere containing 
5% CO2.
synthesis of poly(L-lactide)
The poly(L-lactide) (PLLA) macromer was prepared by 
ring-opening copolymerization of L-lactide initiated by 1,4-
butanediol, as shown in Figure 1. The calculated L-lactide and 
1,4-butanediol were changed to a three-neck round bottle flask 
in a nitrogen atmosphere. Dry toluene was transferred into the 
flask, followed by addition of stannous octoate (0.05% w/w 
in toluene). The system was then kept at 130°C for 14 hours. 
The resulting copolymer was purified using analytical grade 
dichloromethane, and then precipitated in excess cold petro-
leum ether. The mixture was then filtered and dried at room 
temperature under vacuum for 24 hours. The purified copo-
lymers were kept in a desiccator until further use.
synthesis and characterization of  
NcO-ended PLLA macromer
The PLLA obtained was dissolved in 1,1,1-trichloroethane. 
A calculated amount of IPDI was added. The solution was 
then placed in a three-neck glass bottle flask equipped with a 
reflux condenser, a nitrogen inlet tube, and a magnetic stirrer. 
The mixture was heated to 80°C for six hours. The reaction 
system was cooled to room temperature under a nitrogen 
atmosphere, and the mixture was then precipitated in excess 
cold petroleum ether, filtered, and dried to a constant weight 
at 30°C under vacuum. The purified copolymer was kept in 
a desiccator until further use.
synthesis and characterization of  
PLLA-IPDI-PeI
IPDI-PLLA-IPDI and PEI were dissolved in 1,1,1-trichloroethane. 
The PEI solution was transferred into a three-neck round-
bottomed flask equipped with a reflux condenser and stirred 
at 40°C under nitrogen atmosphere. The IPDI-PLLA-IPDI 
solution was then added dropwise through a constant pressure 
infundibulum at 5–10 drops per minute. The system was kept 
at 80°C for another six hours. The resultant copolymer was 
cooled to room temperature and then precipitated in excess cold 
petroleum ether. The mixture was thereafter filtered and dried 
at room temperature under vacuum for 24 hours. The purified 
copolymers were kept in a desiccator until further use.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Fourier transform infrared absorption 
spectra
Fourier transform infrared absorption spectra were recorded 
on a Nicolet 200SXV infrared spectrophotometer (Nicolet 
Instruments, Madison, WI). The copolymer samples were 
prepared after swelling with dichloromethane, mixed with 
KBr powder, and then pressed into pellets. The spectra were 
collected over the range of 4000–5000 cm−1.
1h nuclear magnetic resonance analysis
1H nuclear magnetic resonance (NMR) spectra of PLLA and 
PEA copolymer were recorded on a Varian 400 spectrometer 
(Varian Medical Systems, Palo Alto, CA) at 400 mHz, using 
tetramethylsilane as an internal reference and CDCl3 and 
D2O as the solvent.
Preparation of copolymer/DNA 
complexes
The whole coding sequence of green fluorescent protein was 
inserted into pcDNA3.1 (Invitrogen, San Diego, CA) which 
contains a CMV promoter to construct the plasmid green 
fluorescent protein expressing green fluorescent protein. 
A plasmid DNA stock solution (2 mg/mL) was prepared in pure 
water solution. PEA was dissolved in distilled water to form a 
solution of 2 mg/mL. The PEA/DNA complexes were prepared 
by adding PEA copolymer solution to the DNA solution at the 
desired weight ratio and mixed gently. The complexes were 
incubated at 37°C for 30 minutes before further application. 
Figure 5 shows possible structure of complexes from plasmid 
DNA condensation using PLLA-PEI (PEA) copolymers.
Gel retardation assays
The extent and effectiveness of DNA condensation by PEA 
were evaluated using the gel retardation assay. The PEA and 
DNA solutions were mixed at various weight ratios and incu-
bated for 30 minutes at room temperature to allow complex 
formation. The PEA/DNA complexes were dissolved in a 
1% (w/v) agarose gel pretreated with 0.5 mg/mL ethidium 
bromide in Tris-boric acid-ethylenediamine tetra-acetic acid 
buffer at 80 V .
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Determination of complex size and zeta 
potential
The particle size and zeta potential were measured on 
a zetasizer 3000 HS (Malvern, Worcestershire, UK) at 
room temperature. The complexes at various weight ratios 
were prepared by adding an appropriate volume of DNA solu-
tion to appropriate volumes of PEA solution. The complexes 
were then incubated at room temperature for 30 minutes. 
After that, the polyplexes were diluted for measurement.
cytotoxicity determination
Cyototoicity evaluation of the PEA copolymer was measured 
with an MTT assay using HEK293 and HepG-2 cells. Cells 
were plated in 96-well plates at an initial density of 5 × 105 
cells per well in 200 µL of growth medium for 24 hours. 
Afterwards, the growth medium was replaced with fresh 
medium, and different amounts of PEA copolymer were 
added. After 24 hours, the cell cultures were washed with 
fresh medium and the MTT assay was conducted. Untreated 
cells were used as controls with 100% viability. The cytotox-
icity of PEA copolymer was defined as the relative viability 
(%) correlating with the amount of viable cells compared 
with the control cells.
In vitro transfection
The HEK293 cells were seeded in a 24-well plate at an initial 
density of 1 × 105 cells per well in 2 mL growth medium and 
incubated for 20–24 hours to achieve 80% confluency. The 
following day, wells were washed with l mL of phosphate-
buffered saline and the medium was replaced. PEA/DNA 
complexes formed at various weight ratios were added to 
the wells for four hours before replacing the medium. After 
24 hours, transfection efficiency was estimated by the amount 
of transfected cells with green fluorescent protein that were 
observed using a fluorescence inverted microscope (IX71, 
Olympus), and photographed by Spot Flex. Each experiment 
was precise quantitatively analyzed by flow cytometry.
statistical analysis
Quantitative data are expressed as means ± standard devia-
tion. Statistical analysis was performed by single-factor 
analysis of variance. P values less than 0.05 were considered 
to be statistically significant.
Results
synthesis and character of PeA 
composites
Figure 2 shows the 1H-NMR spectrum of the synthesized 
PLLA macromer. Peaks C and A were assigned to the 
methyl protons of −O−CH(CH3)CO− and HO−CH(CH3)−
 C O − in PLLA. The peaks F and E were attributed to the 
methylene protons of the two middle −CH2− and the 
end −CH2− in 1,4-butanediol. The peaks D and B were 
attributed to the tertiary proton of −O−CH(CH3)CO− and 
HO−CH(CH3)−CO− in PLLA.
The macromolecular weight (Mn) of the PLLA macromer 
was calculated from 1H-NMR spectra according to the fol-
lowing equation:
 
2X
Id
=
4
If  
  Mn(PLLA) = (73 + 72 × X) × 2 + 88 = 144X + 234 
where Id and If were the integral intensities of peaks at 
5.193 ppm and 3.608 ppm in the 1H-NMR spectrum of PLLA 
(Figure 2). The macromolecular weight of  the PLLA macromer 
was calculated to be 490 according to the 1H-NMR spectrum. 
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Figure 2 representative 1h-nuclear magnetic resonance spectrum (400 mhz) of PLLA copolymer in cDcl3.
Note: In the h-nuclear magnetic resonance spectra, the chemical shifts of the TMs (si(ch3)4), as relative standard, were defined zero.
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The 1H-NMR spectrum of the resulting PLLA-PEI based on 
the reaction of IPDI-PLLA-IPDI and low molecular weight 
branched PEI (molecular weight 2000 Da) is shown in Figure 3, 
The broad peaks at 2 ppm and 3 ppm are attributed to the pro-
tons of −NHCH2CH2− in the PEI moiety of PLLA-PEI.
Figure 4 shows the typical Fourier transform infrared 
spectra of the PLLA, IPDI-PLLA-IPDI, and PEA compos-
ite. In Figure 4A, the absorption peaks at 2991.00 cm−1 and 
2994.56 cm−1 represent the bending vibration of −CH3− and 
−CH2−. The peaks at 1745.61 cm-1 belong to the ester car-
bonyl (C=O). The wide absorption band at 3476.28 cm−1 
is assigned to the terminal hydroxyl groups (−OH) in the 
copolymer. In Figure 4B, there is a strong absorption in 
2266.17 cm−1 which is attributed to the −NCO stretching 
vibrations, and the absorption peak at 1726.06 cm−1 rep-
resents the bending vibration of urethane carbonyl (C=O). 
It is clear that PLLA only reacted with one −NCO in IPDI, 
which is more active than the other. In Figure 4C, there is 
no absorption at 2250–2270 cm−1, which indicates that the 
−NCO groups of IPDI disappears completely due to the 
coupling reaction of −NCO with −NH2. A weak peak at 
1734 cm−1 belongs to ester carbonyl (C=O) which could be 
seen and enhanced obviously in composite. The absorption 
band at 1645.69 cm−1 is attributed to the stretching vibration 
of urea carbonyl (C=O) in the PEA macromer.
Gel retardation assay
In this study, to determine the optimal concentration for com-
plete inhibition of DNA, the PEA and DNA solutions were 
mixed at various w/w PEA/DNA ratios keeping the amount 
of DNA (2 µg) constant, and incubated for 30 minutes at 
room temperature to allow formation of the complexes. 
Figure 6 shows the results of agarose gel electrophoresis 
of the PEA/DNA complexes at various weight ratios (from 
0.01 to 1). Naked DNA was used as the control group. It is 
obvious that increasing amounts of PEA in the complexes led 
to decreased electrophoretic mobility. When the weight ratio 
(carrier to gene) was 0.5, the PEA/DNA complexes showed 
complete retardation and the band completely disappeared.
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Particle size and zeta potential
The particle size of the PEA/DNA complexes at various 
weight ratios (carrier to DNA) ranging from 0.1 to 16 were 
measured by adding different volumes of PEA solution to 
DNA solutions at physiological ionic strength (in 0.9% NaCl 
solution). As shown in Figure 7, the particle size gradually 
decreases with increasing weight ratio due to the net positive 
electrostatic repulsion between complexes. At a PEA/DNA 
weight ratio of 0.1, the particle size is 551 nm, indicating poor 
complexation between DNA and PEA. At a PEA/DNA weight 
ratio of 1, the size of the PEA/DNA nanoparticles reduced to 
140 nm. At a PEA/DNA weight ratio of 1 and 16, the particle 
sizes of PEA/DNA complexes are less than 150 nm.
Figure 7 indicates that the majority of PEA condensed 
DNA into nanoparticles with significant surface charges. 
At a carrier to DNA weight ratio of 0.1, the zeta potential 
was −2.1 mV , indicating poor complexation between DNA 
and PEA. As expected, the zeta potential rapidly increased, 
with an increasing carrier to DNA weight ratio from 0.5 to 
16. Average zeta potentials of the PEA/DNA complexes 
ranged from 3.7 to 15.2 mV .
In vitro cytotoxicity
Figure 8 shows the results for the in vitro cytotoxicity of 
PEA and PEI (25 kDa) analyzed by the MTT method in the 
HEK293 and HepG-2 cell lines. Cell viability was calculated 
according to the following equation:
  Cell viability (%) = OD570(sample)/OD570(control) × 100
where OD570(control) was obtained in the absence of polymers 
and OD570(sample) was obtained in the presence of polymers. As 
shown in Figure 8, PEA and PEI (25 kDa) showed a strong dose-
dependent effect on cytotoxicity. No significant cytotoxicity was 
found among the various polymers at the low concentration 
(#2 ug/mL). However, with increasing concentration, PEA 
was found to have much lower cytotoxicity than PEI (25 kD) 
in the HEK293 and HepG-2 cell lines (P , 0.05).
In vitro transfection
The gene delivery efficiency of PEA based on PLA and low 
molecular weight PEI was evaluated by in vitro transfection 
experiments in HEK293 cells using plasmid DNA. For rapid 
examination, PEA/DNA polyplexes formed at various carrier to 
DNA weight ratios were added to HEK293 cell cultures followed 
by incubation. After transient transfection and additional 
incubation for 24 hours, transfection efficiency was analyzed 
quantitatively using flow cytometry, and transfection images were 
observed by fluorescence inverted microscopy and photographed 
by Spot Flex. Surprisingly, the most efficient gene expression 
of PEA was observed at the carrier to DNA weight ratio of 2:1. 
The highest transfection efficiency of PEA was 44% ± 3%, as 
shown in Figure 9, while the optimized transfection efficiency 
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at various weight ratios.
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Figure 10 High transfection efficiency images of (A) polyethylenimine (25 kDa) and 
(B) poly(ester amine)/DNA were shown in cell lines heK293.
Notes: cells were incubated with polyethylenimine (25 kDa)/DNA and poly(ester 
amine)/DNA complexes at carrier to gene weight ratios of 2 and 1.5 for 24 hours; 
green fluorescent protein expression was observed under fluorescent microscopy.
of the control PEI (25 kDa) was 34% ± 4% at the carrier to 
DNA weight ratio of 1.5:1.0, which equals an N/P ratio of 10:1. 
Figure 10 shows the high transfection efficiency images for PEI 
(25 kDa) and PEA in the HEK293 cell lines.
Discussion
The aim of this research was to develop and optimize delivery 
systems for plasmid DNA. In this paper, we successfully 
  synthesized a novel biodegradable PEA copolymer based 
on PLA and low molecular weight PEI, which showed 
degradability, a good ability to form complexes with 
DNA, and suitable physicochemical properties for a gene 
delivery system. These polymers had less cytotoxicity and 
exhibited much higher gene transfer efficiency than PEI 
(25 kDa) itself. Therefore, it is expected that this PEA 
will have the potential to be a safe gene carrier owing to 
its degradability, low cytotoxicity, and high transfection 
efficiency.
The condensation of anionic DNA into small particles 
is an important prerequisite for gene carriers employing 
  polycations.12 From Figure 6, when the carrier to DNA weight 
ratio is greater than 0.5, the PEA polymer can concentrate 
DNA, and can protect against DNase I. Meanwhile, the small 
and compact complex particle is critically important for 
polycations used as gene vectors,13 and particle size would 
apparently affect the transfection efficiency of gene vectors.14 
Particle size depends on many parameters, including DNA International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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concentration, sequence of addition of polycations or DNA 
during complex preparation, and the ionic strength of the 
  solvent.15 Large particles in the micrometer range in the 
vascular periphery are poorly internalized by the cells, so 
the desirable in vivo vectors should be small (below 150 nm) 
and compact for good systemic circulation and effective 
endocytosis.16–18 From Figure 7, showing a weight ratio 
between 1 and 16, the particle sizes of PEA/DNA complexes 
are smaller than the 150 nm limit for effective endocytosis. 
The particle size decreased with increasing charge ratio. 
This was due to the strong electrostatic interactions between 
the polymer and DNA. The positively charged complexes 
would bind to the negatively charged cellular membrane, 
facilitating the entry of the complexes into cells by cellular 
uptake.19–21 From Figure 7, when the carrier to DNA weight 
ratio is greater than 0.5, the average zeta potential of the 
PEA/DNA complexes ranged from 3.67 mV to 15.2 mV. 
Therefore, PEA is expected to be a suitable candidate for 
effective transfection owing to its ideal particle size and 
significant surface charge.
The cytotoxicity of a polymeric gene vector may be 
an important factor affecting transfection efficiency. It is 
generally thought that the polycation cytotoxicity is caused 
by polymer aggregation on the cell surface due to strong 
electrostatic interactions in the plasma membrane, which 
impairs cell membrane function.22,23 Bieber and Elsasser 
suggested that there is a correlation between cytotoxicity and 
molecular weight.12 It has already been reported that high 
molecular weight PEI is significantly more cytotoxic than 
low molecular weight PEI.20 In this research, the cytotoxicity 
of PEA and PEI (25 kDa) was also analyzed using the MTT 
assay. From Figure 8, with increasing concentrations, PEA 
complexes were found to be much less cytotoxic than PEI 
(25 kDa) in the HEK293 and HepG-2 cells, which indicates 
that a wider dose range of polymer could be selected for gene 
transfer. PEI (25 kDa), which displays cytotoxicity, has no 
degradation or excretion pathway in vivo. Therefore, it may 
accumulate in vivo, resulting in increased cytotoxicity.24 
Owing to the backbone of the PLA and low molecular weight 
PEI (2000 Da), the synthesized PEA can be expected to have 
better biocompatibility.
PEIs with a molecular weight of 25 kDa or greater have 
shown good transfection efficiency both in vitro and in 
vivo.25,26 However, these higher molecular weight cationic 
polymers induce rapid necrotic-like changes resulting from 
perturbation of the plasma membrane and the activation of 
mitochondrial-mediated apoptosis.27 Low molecular weight 
PEI (2000 Da) displayed much less cytotoxicity but almost 
no transfection activity.28 Thus, PEI (#2000 Da) was used 
in the current study not just because of its endosomolytic 
function, but also because of its lower cytotoxicity and lower 
background transfection efficiency. Relatively, compared 
with PEI (25 kDa), we attempted to achieve low cytotoxic-
ity and to increase the transfection efficiency of the nonviral 
gene carriers. From Figure 9, it is clear that the transfection 
efficiency of PEA is higher than that of the gold standard, PEI 
(25 kDa). Our results demonstrate that degradable, disulfide-
crosslinked, low molecular weight PEI has higher gene trans-
fection efficiency and lower cytotoxicity than nondegradable 
high molecular weight PEI (25 kDa). Therefore, these PEAs 
can be used as efficient vectors, providing a versatile platform 
for further investigation of their structure-property relation-
ship, along with fair stability, significantly low cytotoxicity, 
and high transfection efficiency.
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